103 related articles for article (PubMed ID: 689945)
1. Immune competence and survival in patients with advanced cervical cancer: peripheral lymphocyte counts.
DiSaia PJ; Morrow CP; Hill A; Mittelstaedt L
Int J Radiat Oncol Biol Phys; 1978; 4(5-6):449-51. PubMed ID: 689945
[No Abstract] [Full Text] [Related]
2. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
Ishiguro T; Sugitachi I; Katoh K
Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
[No Abstract] [Full Text] [Related]
3. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer.
Lee YY; Choi CH; Sung CO; Do IG; Hub SJ; Kim HJ; Kim TJ; Lee JW; Bae DS; Kim BG
Gynecol Oncol; 2012 Oct; 127(1):107-13. PubMed ID: 22710071
[TBL] [Abstract][Full Text] [Related]
5. Changes in cell numbers and activities of lymphocyte-subpopulations in the progress of uterine cervical cancer.
Ueda K; Nakamori H; Umesaki N; Sako H; Hayashi M
Osaka City Med J; 1975; 21(2):97-109. PubMed ID: 1230725
[No Abstract] [Full Text] [Related]
6. Immunological status in cervical cancer in relation to pelvic irradiation.
Chandra M; Chander S
Indian J Med Res; 1986 Oct; 84():413-7. PubMed ID: 3781598
[No Abstract] [Full Text] [Related]
7. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of lymphocyte and eosinophil counts in resectable cervical squamous cell carcinoma.
Zhu J; Wang H; Gao MJ; Li YF; Huang YQ; Shi JP; Wang WJ
Future Oncol; 2019 Oct; 15(30):3467-3481. PubMed ID: 31580723
[No Abstract] [Full Text] [Related]
9. Immunoglobulins in carcinoma of the uterine cervix.
Plesnicar S
Acta Radiol Ther Phys Biol; 1972 Feb; 11(1):37-47. PubMed ID: 4623041
[No Abstract] [Full Text] [Related]
10. Interleukin 2 production in lymphocyte cultures: a rapid test for cancer-associated immunodeficiency in malignant cervical neoplasia.
Radhakrishna Pillai M; Balaram P; Bindu S; Hareendran NK; Padmanabhan TK; Nair MK
Cancer Lett; 1989 Oct; 47(3):205-10. PubMed ID: 2699725
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer].
Chen X; Zhang G
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):208-12. PubMed ID: 24820307
[TBL] [Abstract][Full Text] [Related]
13. [Changes of lymphocyte subsets in peripheral blood and cancer tissue during radiotherapy--analysis with monoclonal antibodies].
Ogawa Y; Hamada F; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Maeda T
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Nov; 44(11):1417-9. PubMed ID: 6531200
[No Abstract] [Full Text] [Related]
14. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
Twomey PL; Rogentine GN; Chretien PB
Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
[No Abstract] [Full Text] [Related]
16. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG
Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
[TBL] [Abstract][Full Text] [Related]
17. [Determination of serum copper and ceruloplasmin levels in patients with cervical cancer].
Yu SY; Zhang L
Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):15-7, 61. PubMed ID: 3595303
[No Abstract] [Full Text] [Related]
18. T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.
Rand RJ; Jenkins DM; Bulmer R
Clin Exp Immunol; 1978 Jul; 33(1):159-65. PubMed ID: 309370
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity in squamous cell carcinoma of the uterine cervix.
Levy S; Kopersztych S; Musatti CC; Souen JS; Salvatore CA; Mendes NF
Am J Obstet Gynecol; 1978 Jan; 130(2):160-4. PubMed ID: 304309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
